Haleon PLC (HLN) - Total Assets

Latest as of June 2025: GBX31.83 Billion GBX ≈ $3.87 Million USD

Based on the latest financial reports, Haleon PLC (HLN) holds total assets worth GBX31.83 Billion GBX (≈ $3.87 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Haleon PLC - Total Assets Trend (2019–2024)

This chart illustrates how Haleon PLC's total assets have evolved over time, based on quarterly financial data. Also see Haleon PLC market cap and net worth for the company's overall valuation and market capitalisation.

Haleon PLC - Asset Composition Analysis

Current Asset Composition (December 2024)

Haleon PLC's total assets of GBX31.83 Billion consist of 16.7% current assets and 83.3% non-current assets. Review HLN current and long-term liabilities to assess the company's total debt and financial obligations.

Asset Category Amount (GBX) % of Total Assets
Cash & Equivalents GBX0.00 6.4%
Accounts Receivable GBX1.90 Billion 5.6%
Inventory GBX1.19 Billion 3.5%
Property, Plant & Equipment GBX0.00 0.0%
Intangible Assets GBX18.01 Billion 52.5%
Goodwill GBX8.20 Billion 23.9%

Asset Composition Trend (2019–2024)

This chart illustrates how Haleon PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Haleon PLC (HLN) share price today for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Haleon PLC's current assets represent 16.7% of total assets in 2024, an increase from 16.3% in 2019.
  • Cash Position: Cash and equivalents constituted 6.4% of total assets in 2024, up from 1.0% in 2019.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 75.0% of total assets, a decrease from 77.0% in 2019.
  • Asset Diversification: The largest asset category is intangible assets at 52.5% of total assets.

Haleon PLC Competitors by Total Assets

Key competitors of Haleon PLC based on total assets are shown below.

Company Country Total Assets
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Germany €1.60 Trillion
GALDERMA GROUP AG
NYSE:GALDY
USA $13.39 Billion
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
USA $15.42 Trillion
Beijing Tongrentang Co Ltd
SHG:600085
China CN¥31.82 Billion
Takeda Pharmaceutical Company Limited
F:TKDA
Germany €15.41 Trillion
Changchun High & New Technology Industries Group Inc
SHE:000661
China CN¥30.77 Billion
Neuland Laboratories Limited
NSE:NEULANDLAB
India Rs29.30 Billion
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062
China CN¥17.01 Billion

Haleon PLC - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.87 0.84 1.24
Quick Ratio 0.63 0.58 1.01
Cash Ratio 0.00 0.00 0.00
Working Capital GBX-620.00 Million GBX-914.00 Million GBX1.01 Billion

Haleon PLC - Advanced Valuation Insights

This section examines the relationship between Haleon PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.11
Latest Market Cap to Assets Ratio 0.01
Asset Growth Rate (YoY) 0.8%
Total Assets GBX34.31 Billion
Market Capitalization $368.96 Million USD

Valuation Analysis

Below Book Valuation: The market values Haleon PLC's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Haleon PLC's assets grew by 0.8% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Haleon PLC (2019–2024)

The table below shows the annual total assets of Haleon PLC from 2019 to 2024.

Year Total Assets Change
2024-12-31 GBX34.31 Billion
≈ $4.18 Million
+0.76%
2023-12-31 GBX34.05 Billion
≈ $4.14 Million
-2.18%
2022-12-31 GBX34.81 Billion
≈ $4.24 Million
+1.06%
2021-12-31 GBX34.45 Billion
≈ $4.19 Million
+0.94%
2020-12-31 GBX34.13 Billion
≈ $4.15 Million
-4.43%
2019-12-31 GBX35.71 Billion
≈ $4.34 Million
--

About Haleon PLC

LSE:HLN UK Drug Manufacturers - Specialty & Generic
Market Cap
$368.96 Million
GBX3.03 Trillion GBX
Market Cap Rank
#13886 Global
#64 in UK
Share Price
GBX340.50
Change (1 day)
-0.50%
52-Week Range
GBX320.90 - GBX410.90
All Time High
GBX415.20
About

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene… Read more